Literature DB >> 6359018

Electromyographic (EMG) feedback in chronic musculoskeletal pain: a controlled trial.

Robert G Large1, Ann M Lamb.   

Abstract

The literature regarding the application of EMG feedback training in musculoskeletal pain disorders is reviewed. A within-subject control trial of EMG feedback using a counterbalanced design in patients with chronic musculoskeletal pain is reported here. Eighteen subjects (12 females and 6 males) were studied in terms of subjective reports of pain and EMG activity measurement under standardised conditions. Both EMG feedback and a control condition were active in reducing subjective pain levels, which increased during a waiting list conditions in certain sequences. EMG activity declined during both EMG feedback and control conditions but only EMG feedback resulted in an orderly reduction in EMG baseline measurements with a highly significant linear trend when presented before the control condition in sequence. A significant correlation between subjective pain levels and surface EMG activity was found. These data suggest that EMG feedback is superior to a control condition in training muscle relaxation but not in reducing subjective pain levels despite a high correlation between these two parameters. Non-specific factors may well affect pain scores and further research is required before the specific biofeedback training effect can be accepted as superior to its non-specific effects in reducing subjective pain.

Entities:  

Mesh:

Year:  1983        PMID: 6359018     DOI: 10.1016/0304-3959(83)90140-9

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  2 in total

1.  Two psychological interventions are effective in severely disabled, chronic back pain patients: a randomised controlled trial.

Authors:  Julia Anna Glombiewski; Jens Hartwich-Tersek; Winfried Rief
Journal:  Int J Behav Med       Date:  2010-06

Review 2.  Efficacy of EMG- and EEG-Biofeedback in Fibromyalgia Syndrome: A Meta-Analysis and a Systematic Review of Randomized Controlled Trials.

Authors:  Julia Anna Glombiewski; Kathrin Bernardy; Winfried Häuser
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-03       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.